Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies.

"Disclosure of potential conflict of interest: S. Weidinger is coprincipal investigator of the German Atopic Eczema Registry TREATgermany; has received institutional research grants from Sanofi Deutschland GmbH, Leo Pharma, and La Roche Posay; has performed consultancies for Sanofi-Genzyme, Regeneron, LEO Pharma, AbbVie, Pfizer, Eli Lilly, Kymab, and Novartis; has also lectured at educational events sponsored by Sanofi-Genzyme, Regeneron, LEO Pharma, AbbVie, Novartis, and Galderma; and is involved in performing clinical trials with many pharmaceutical industries that manufacture drugs used for the treatment of psoriasis and atopic eczema. J. E. Gudjonsson received research grants from Almirall, Eli Lilly, Kyowa Kirin, and SunPharma, and serves as advisory board member for Novartis, Eli Lilly, Almirall, and AnaptysBio. The rest of the authors declare that they have no relevant conflicts of interest."

"This work was supported by the Arthritis National Research Foundation and the National Psoriasis Foundation (L.C.T. and M.T.P.), National Psoriasis Foundation’s Psoriasis Prevention Initiative (L.C.T. and J.E.G.), and awards from the 10.13039/100000002National Institutes of Health (grant nos. R01AR042742, R01AR050511, R01AR054966, R01AR063611, and R01AR065183 to J.T.E. and grant no. K01AR072129 to L.C.T.). L.C.T. was also supported by the 10.13039/100001582Dermatology Foundation, and M.T.P. was supported by a Precision Health Scholars Award from the 10.13039/100007270University of Michigan. L.C.T., J.E.G., and J.T.E. are supported by the Dawn and Dudley Holmes Foundation and the Babcock Memorial Trust. J.E.G. was supported by the 10.13039/100000002National Institutes of Health (grant nos. K08AR060802 and R01AR06907) and the 10.13039/100008456Taubman Medical Research Institute as the Frances and Kenneth Eisenberg Emerging Scholar. L.C.T. and J.E.G. are also supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (10.13039/100000069NIAMS; grant no. UM-SBDRC 1P30AR075043) and the Taubman Institute Innovation Project. J.T.E. is supported by the Ann Arbor Veterans Affairs Hospital."